Home  /  Resource Library  /  Persistent covid-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma

Persistent covid-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma

Case report of a patient with follicular lymphoma who developed COVID-19 pneumonia.